GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » YoY EBITDA Growth

ClouDr Group (HKSE:09955) YoY EBITDA Growth : -105.59% (As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ClouDr Group YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ClouDr Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -105.59%.

ClouDr Group's EBITDA per Share for the six months ended in Dec. 2024 was HK$-0.66.

ClouDr Group YoY EBITDA Growth Historical Data

The historical data trend for ClouDr Group's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ClouDr Group YoY EBITDA Growth Chart

ClouDr Group Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
YoY EBITDA Growth
Get a 7-Day Free Trial -454.33 -49.97 34.11 92.85 -62.71

ClouDr Group Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only 75.13 87.07 62.69 35.22 -105.59

ClouDr Group YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ClouDr Group's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (A: Dec. 2024 )
=(EBITDA per Share (A: Dec. 2024 )-EBITDA per Share (A: Dec. 2023 ))/ | EBITDA per Share (A: Dec. 2023 ) |
=(-0.685--0.421)/ | -0.421 |
=-62.71 %

ClouDr Group's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

YoY EBITDA Growth (Q: Dec. 2024 )
=(EBITDA per Share (Q: Dec. 2024 )-EBITDA per Share (Q: Dec. 2023 )) / | EBITDA per Share (Q: Dec. 2023 )) |
=(-0.662--0.322)/ | -0.322 |
=-105.59 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ClouDr Group YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of ClouDr Group's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ClouDr Group Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » ClouDr Group Ltd (HKSE:09955) » Definitions » YoY EBITDA Growth
Comparable Companies
HKSE:02289 HKSE:08223 HKSE:06833 HKSE:00718 HKSE:00673 HKSE:08372 HKSE:00401 HKSE:00314 HKSE:01931 MCK COR CAH ASX:SIG HSIC SHSE:601607 HKSE:01099 SHSE:600332 XSWX:GALE MIL:AMP NZSE:EBO
Traded in Other Exchanges
N/A
Address
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
Website
https://www.cloudr.cn
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies, and out-of-hospital solution connects doctors and patients, and provides high-quality and trustworthy medical services through AI vertical model ClouD GPT. The company generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.
Executives
Futu Trustee Limited 2301 Trustee
Kuang Ming 2201 Interest of corporation controlled by you
Trident Trust Company (hk) Limited 2301 Trustee
Data Vantage Development Limited 2201 Interest of corporation controlled by you
Prime Forest Assets Limited 2101 Beneficial owner
Zhou Quan 2201 Interest of corporation controlled by you
Shang Hai Qi Ji Ke Ji He Huo Qi Ye You Xian He Huo
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Zhao Yin Guo Ji Jin Rong You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si
Zhao Yin Guo Ji Jin Rong Kong Gu Shen Zhen You Xian Gong Si
Ho Chi Sing 2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd.
Explorer Partner Corp.
Idg China Venture Capital Fund Gp Iv Associates Ltd. 2201 Interest of corporation controlled by you

ClouDr Group Headlines

No Headlines